UCB hands European Xyzal remit to Aurora

Start-up agency Aurora has bagged its biggest account to date by a country mile, scooping a pan-European brief for Belgium pharma firm UCB's prescription antihistamine Xyzal.

The brief will consist of consumer and medical awareness campaigns and focus on ‘the impact of allergies on society’. Fees are believed to be worth around £300,000 over the 18 months until December 2007.

There has been an explosion in allergic reactions among Brits, with the country ‘in the grip of an allergy epidemic’ according to one Daily Telegraph article.

Aurora will work across the UK, France, Spain, Italy, Germany, Belgium and Greece, while programmes are also under consideration in other countries. It will develop campaigns that can either be implemented by UCB’s in-country agencies or local freelancers sourced by Aurora.

Agency joint MD Neil Crump previously handled the European Xyzal account at Athena Medical PR, where he was board director until resigning last autumn to set up Aurora with Claire Eldridge (PRWeek, 9 Dec 2005). In May, Roche hired Aurora on a UK HIV contract (PRWeek, 12 May).

The agency has also conducted a ‘key message workshop’ for the Medicines and Healthcare products Regulatory Agency.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.